Indication

Atrioventricular block

Atrioventricular block is a cardiac conduction disorder characterized by delayed or interrupted transmission of electrical impulses from the atria to the ventricles. Read more about Atrioventricular block

16 drugs 15 manufacturers

Advertisement

Drugs that treat it

Common Atrioventricular block therapies.

Showing 1–9 of 16 drugs

ISOPROTERENOL HCL

BETA-ADRENERGIC AGENTS·ATRIOVENTRICULAR BLOCK·+4
Amphastar Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Atrioventricular block preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Atrioventricular block.

Atrioventricular block is a cardiac conduction disorder characterized by delayed or interrupted transmission of electrical impulses from the atria to the ventricles.

Arising from structural degeneration, ischemia, inflammatory disease, or medication-induced impairment within the atrioventricular node or the His-Purkinje system, it affects cardiovascular hemodynamics across diverse patient populations.

Clinically, it is classified by electrophysiologic severity into first-degree (conduction delay), second-degree (intermittent failure of impulse propagation), and third-degree or complete heart block (total absence of atrioventricular conduction accompanied by an independent escape rhythm).

Manifestations vary according to the degree and anatomical site of the block, ranging from asymptomatic electrocardiographic prolongation to profound bradycardia, syncope, fatigue, or hemodynamic collapse.

Personalize your experience

Follow Atrioventricular block and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it